Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers

Journal of Clinical Pharmacology

Volumn 40, Issue 12 I, 2000, Pages 1312-1322

  Stangier, Joachim ^a   Schmid, Jochen ^a   Türck, Dietrich ^a   Switek, Heinz ^a   Verhagen, Aalt ^b   Peeters, Pierre A M ^b   van Marle, Sjoerd P ^b   Tamminga, Wim J ^b   Sollie, Frans A E ^b   Jonkman, Jan H G ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b PRA International USA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CARBON 14; DRUG METABOLITE; GLUCURONIDE; OROSOMUCOID; PLASMA PROTEIN; TELMISARTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; FAINTNESS; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; VERTIGO;

ABSORPTION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; CARBON RADIOISOTOPES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033740069     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127000004001202     Document Type: Article

References (23)

1. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease
2. Historical perspective on renin system blockade in the treatment of hypertension
3. Angiotensin II receptors and angiotensin II receptor antagonists
4. Angiotensin receptors and their antagonists
5. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema
6. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: Synthesis, biological activity, and structure-activity relationships
7. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277
8. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
9. Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers
10. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man
11. 14C-candesartan cilexetil in healthy volunteers
12. Human plasma protein binding of angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174
13. Clinical pharmacokinetics of telmisartan
14. Drug binding in plasma: A summary of recent trends in the study of drug and hormone binding
15. Special in vitro and in vivo investigations on the pharmacokinetics of telmisartan and its glucuronide
16. 1 receptor antagonist telmisartan in patients with mild to moderate hypertension
17. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists
18. In vitro glucuronidation of telmisartan, a novel angiotensin II receptor antagonist
19. In vivo and in vitro biotransformation of telmisartan, human hepatocyte cultures as an aid in human metabolic studies
20. In vivo and in vitro biotransformation of telmisartan
21. Structure elucidation of the main metabolite of telmisartan
22. Recent insight into therapy of congestive heart failure: Focus on ACE inhibition and angiotensin-II antagonism
23. Drug-induced severe skin reactions: Incidence, management and prevention